Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
GENE:
BRAF (B-raf proto-oncogene)
i
Other names:
BRAF, B-raf proto-oncogene, B-raf proto-oncogene, Serine/threonine kinase, V-Raf murine sarcoma viral oncogene homolog B, Serine/threonine-protein kinase B-Raf, Proto-oncogene B-Raf, BRAF1, RAFB1, B-raf proto-oncogene Serine/threonine-protein kinase, Murine sarcoma viral (V-Raf) oncogene homolog B1, B-raf serine/threonine-protein, 94 KDa B-raf protein, B-RAF1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
673
Related tests:
‹
FoundationOne® CDx (110)
Guardant360® CDx (54)
FoundationOne® Liquid CDx (21)
MSK-IMPACT (21)
THXID® BRAF Kit (12)
FoundationOne® Heme CDx (10)
Oncomine™ Dx Target Test (10)
cobas® 4800 BRAF V600 Mutation Test (6)
TruSeq®Amplicon - Cancer Panel (5)
Oncomine™ Pan-Cancer Cell-Free Assay (4)
OncoDEEP (3)
TruSight Oncology 500 Assay (3)
Guardant360 TissueNext™ (2)
Oncomine™ Comprehensive Assay v3M (2)
therascreen® BRAF V600E RGQ PCR (2)
AmoyDx® Pan Lung Cancer PCR Panel (1)
Archer® FusionPlex® Comprehensive Thyroid & Lung (CTL) Kit (1)
InVisionFirst®-Lung (1)
LightMix® BRAF V600E/K Kit (1)
Tempus xT Assay (1)
ACTOnco
AML Express™
ASPYRE-Lung
AVENIO Tumor Tissue CGP Kit
AVENIO Tumor Tissue Expanded Kit
AVENIO Tumor Tissue Surveillance Kit
AVENIO Tumor Tissue Targeted Kit
AVENIO ctDNA Expanded Kit
AVENIO ctDNA Surveillance Kit
AVENIO ctDNA Targeted Kit
Altera
AmoyDx® BRAF V600 Mutations Detection Kit
AmoyDx® Essential NGS Panel
AmoyDx® HANDLE Classic NGS Panel
AmoyDx® HANDLE HRR NGS Panel
AnchorAIM® 10 Gene Test for Individualized Treatment of Lung Cancer
AnchorAIM® 72 gene detection for individualized treatment of solid tumors
AnchorAIM® Personalized Treatment of Colorectal Cancer 11 Gene Test
Archer® FusionPlex® Acute Lymphoblastic Leukemia (ALL)
Archer® FusionPlex® Lung Kit
Archer® FusionPlex® Lymphoma
Archer® FusionPlex® Myeloid Kit
Archer® FusionPlex® Oncology Research Kit
Archer® VariantPlex® Comprehensive Thyroid and Lung (CTL) kit
Archer® VariantPlex® Myeloid panel
Archer® VariantPlex® Solid Tumor Kit
Archer™ FusionPlex™ Core Solid Tumor Panel
Archer™ VARIANTPlex™ Complete Solid Tumor panel
Archer™ VARIANTPlex™ Lymphoma panel
Archer™ VARIANTPlex™ Pan Solid Tumor panel
Blueprint Genetics Comprehensive Hereditary Cancer Panel
CNV+ Breast Cancer NGS Panel
DecisionDx®-CMSeq
Droplex BRAF Mutation Test
Find It®
Follow It®
FusionPlex® Dx
FusionPlex® Pan Solid Tumor v2 panel
FusionPlex™ Pan-Heme panel
GALEAS™ Tumor
GeneStrat® test
HDPCR NSCLC RUO Assay
Idylla™ BRAF Mutation Test
Idylla™ EGFR-BRAF+ Mutation Assay
Idylla™ NRAS-BRAF Mutation Test
Idylla™ NRAS-BRAF-EGFR S492R Mutation Assay
Idylla™ ctBRAF Mutation Assay
Idylla™ ctNRAS-BRAF Mutation Test
InVisionSeq™
Ion AmpliSeq Colon and Lung Cancer Research Panel v2
Labcorp® Plasma Complete™
Liquid Trace™ Solid Tumor
LiquidGx™
LiquidHALLMARK®
LiquidPlex™
Lung Cancer 8-Gene Kit
LungCure™ CDx
MEBGEN™ BRAF 3 Kit
MEBGEN™ BRAF Kit
MI Cancer Seek™
Myeloid Molecular Profile
NGS Targeted Hotspot Panel
NeXT Dx™ Test
NeoLAB® Solid Tumor Liquid Biopsy
NeoTYPE® Lung Tumor Profile
NexCourse®
Northstar Select™
NovoFocus™ CRC 2.0
NovoFocus™ NSCLC 2.0 Test
NovoPM™ 2.0
Omics Core
OncoBEAM™ BRAF Kit
OncoGuide™ NCC Oncopanel System
OncoGxOne™
OncoKey™ SL 525 Plus Assay
OncoKey™ SL 60 Plus Assay
OncoPanel™ Assay
OncoSTRAT&GO
OncoScan™ CNV Plus Assay
OncoScreen™ Focus CDx Tissue Kit
OncoaccuPanel™
Oncomine Dx Express Test
Oncomine Focus Assay
Oncomine Lung Cell-Free Total Nucleic Acid Research Assay
Oncomine Myeloid Research Assay
Oncomine Precision Assay
Oncomine Solid Tumor DNA Kit
Oncomine Tumor Mutation Load Assay
Oncomine™ Colon cfDNA Assay
Oncomine™ Comprehensive Assay Plus
Oncomine™ Lung cfDNA Assay
Oncomine™ Myeloid MRD Assays
Oncotype MAP™ Pan-Cancer Tissue Test
OptiSeq™ Colorectal Cancer Panel
OptiSeq™ Lung Cancer & Colon Cancer Early Detection Panel
OptiSeq™ Lung Cancer Panel
OptiSeq™ Pan-Cancer Gene Panel
PGDx elio™ plasma resolve assay
PGDx elio™ tissue complete assay
Plasma-SeqSensei™ NSCLC Kit
Plasma-SeqSensei™ Solid Cancer IVD Kit
PredicineCARE™
PredicineHEME™
QClamp® BRAF Mutation Detection Test
RAS-RAF-SEQ Assay
Resolution ctDx Lung Assay™
SOPHiA DDM™ Myeloid Solution
SOPHiA DDM™ Solid Tumor Plus Solution
SOPHiA Myeloid Plus Solution
SafeSEQ AML MRD Assay
SafeSEQ CRC MRD assay
SureSeq™ CLL + CNV Panel
SureSeq™ Pan-Myeloid Panel
Target Selector™ BRAF Mutation Assay
Target Selector™ NGS Lung Panel
Tempus xF Assay
Tempus xF+ Panel
TheraPrint® test
ThyGeNEXT® + ThyraMIR®
Todai OncoPanel (TOP)
TruSight Myeloid Sequencing Panel
TruSight Oncology Comprehensive
TruSight Tumor 15 Assay
TruSight Tumor 170 Assay
TumorNext-Lynch
UltraSEEK® Colon Panel
UltraSEEK® Lung Panel
UltraSEEK® Melanoma Panel
VENTANA anti-BRAF V600E (VE1) Mouse Monoclonal Primary Antibody
VarMap™ Pan-Cancer NGS Panel
Vartrace® BRAF Panel
iPLEX® HS Lung Panel
oncoReveal™ Core LBx
oncoReveal™ Essential LBx
oncoReveal™ Fusion LBx Panel
oncoReveal™ Multi-Cancer with CNV & RNA Fusion Panel
oncoReveal™ Solid Tumor v2 Panel
FoundationOne® CDx (110)
Guardant360® CDx (54)
FoundationOne® Liquid CDx (21)
MSK-IMPACT (21)
THXID® BRAF Kit (12)
FoundationOne® Heme CDx (10)
Oncomine™ Dx Target Test (10)
cobas® 4800 BRAF V600 Mutation Test (6)
TruSeq®Amplicon - Cancer Panel (5)
Oncomine™ Pan-Cancer Cell-Free Assay (4)
OncoDEEP (3)
TruSight Oncology 500 Assay (3)
Guardant360 TissueNext™ (2)
Oncomine™ Comprehensive Assay v3M (2)
therascreen® BRAF V600E RGQ PCR (2)
AmoyDx® Pan Lung Cancer PCR Panel (1)
Archer® FusionPlex® Comprehensive Thyroid & Lung (CTL) Kit (1)
InVisionFirst®-Lung (1)
LightMix® BRAF V600E/K Kit (1)
Tempus xT Assay (1)
ACTOnco
AML Express™
ASPYRE-Lung
AVENIO Tumor Tissue CGP Kit
AVENIO Tumor Tissue Expanded Kit
AVENIO Tumor Tissue Surveillance Kit
AVENIO Tumor Tissue Targeted Kit
AVENIO ctDNA Expanded Kit
AVENIO ctDNA Surveillance Kit
AVENIO ctDNA Targeted Kit
Altera
AmoyDx® BRAF V600 Mutations Detection Kit
AmoyDx® Essential NGS Panel
AmoyDx® HANDLE Classic NGS Panel
AmoyDx® HANDLE HRR NGS Panel
AnchorAIM® 10 Gene Test for Individualized Treatment of Lung Cancer
AnchorAIM® 72 gene detection for individualized treatment of solid tumors
AnchorAIM® Personalized Treatment of Colorectal Cancer 11 Gene Test
Archer® FusionPlex® Acute Lymphoblastic Leukemia (ALL)
Archer® FusionPlex® Lung Kit
Archer® FusionPlex® Lymphoma
Archer® FusionPlex® Myeloid Kit
Archer® FusionPlex® Oncology Research Kit
Archer® VariantPlex® Comprehensive Thyroid and Lung (CTL) kit
Archer® VariantPlex® Myeloid panel
Archer® VariantPlex® Solid Tumor Kit
Archer™ FusionPlex™ Core Solid Tumor Panel
Archer™ VARIANTPlex™ Complete Solid Tumor panel
Archer™ VARIANTPlex™ Lymphoma panel
Archer™ VARIANTPlex™ Pan Solid Tumor panel
Blueprint Genetics Comprehensive Hereditary Cancer Panel
CNV+ Breast Cancer NGS Panel
DecisionDx®-CMSeq
Droplex BRAF Mutation Test
Find It®
Follow It®
FusionPlex® Dx
FusionPlex® Pan Solid Tumor v2 panel
FusionPlex™ Pan-Heme panel
GALEAS™ Tumor
GeneStrat® test
HDPCR NSCLC RUO Assay
Idylla™ BRAF Mutation Test
Idylla™ EGFR-BRAF+ Mutation Assay
Idylla™ NRAS-BRAF Mutation Test
Idylla™ NRAS-BRAF-EGFR S492R Mutation Assay
Idylla™ ctBRAF Mutation Assay
Idylla™ ctNRAS-BRAF Mutation Test
InVisionSeq™
Ion AmpliSeq Colon and Lung Cancer Research Panel v2
Labcorp® Plasma Complete™
Liquid Trace™ Solid Tumor
LiquidGx™
LiquidHALLMARK®
LiquidPlex™
Lung Cancer 8-Gene Kit
LungCure™ CDx
MEBGEN™ BRAF 3 Kit
MEBGEN™ BRAF Kit
MI Cancer Seek™
Myeloid Molecular Profile
NGS Targeted Hotspot Panel
NeXT Dx™ Test
NeoLAB® Solid Tumor Liquid Biopsy
NeoTYPE® Lung Tumor Profile
NexCourse®
Northstar Select™
NovoFocus™ CRC 2.0
NovoFocus™ NSCLC 2.0 Test
NovoPM™ 2.0
Omics Core
OncoBEAM™ BRAF Kit
OncoGuide™ NCC Oncopanel System
OncoGxOne™
OncoKey™ SL 525 Plus Assay
OncoKey™ SL 60 Plus Assay
OncoPanel™ Assay
OncoSTRAT&GO
OncoScan™ CNV Plus Assay
OncoScreen™ Focus CDx Tissue Kit
OncoaccuPanel™
Oncomine Dx Express Test
Oncomine Focus Assay
Oncomine Lung Cell-Free Total Nucleic Acid Research Assay
Oncomine Myeloid Research Assay
Oncomine Precision Assay
Oncomine Solid Tumor DNA Kit
Oncomine Tumor Mutation Load Assay
Oncomine™ Colon cfDNA Assay
Oncomine™ Comprehensive Assay Plus
Oncomine™ Lung cfDNA Assay
Oncomine™ Myeloid MRD Assays
Oncotype MAP™ Pan-Cancer Tissue Test
OptiSeq™ Colorectal Cancer Panel
OptiSeq™ Lung Cancer & Colon Cancer Early Detection Panel
OptiSeq™ Lung Cancer Panel
OptiSeq™ Pan-Cancer Gene Panel
PGDx elio™ plasma resolve assay
PGDx elio™ tissue complete assay
Plasma-SeqSensei™ NSCLC Kit
Plasma-SeqSensei™ Solid Cancer IVD Kit
PredicineCARE™
PredicineHEME™
QClamp® BRAF Mutation Detection Test
RAS-RAF-SEQ Assay
Resolution ctDx Lung Assay™
SOPHiA DDM™ Myeloid Solution
SOPHiA DDM™ Solid Tumor Plus Solution
SOPHiA Myeloid Plus Solution
SafeSEQ AML MRD Assay
SafeSEQ CRC MRD assay
SureSeq™ CLL + CNV Panel
SureSeq™ Pan-Myeloid Panel
Target Selector™ BRAF Mutation Assay
Target Selector™ NGS Lung Panel
Tempus xF Assay
Tempus xF+ Panel
TheraPrint® test
ThyGeNEXT® + ThyraMIR®
Todai OncoPanel (TOP)
TruSight Myeloid Sequencing Panel
TruSight Oncology Comprehensive
TruSight Tumor 15 Assay
TruSight Tumor 170 Assay
TumorNext-Lynch
UltraSEEK® Colon Panel
UltraSEEK® Lung Panel
UltraSEEK® Melanoma Panel
VENTANA anti-BRAF V600E (VE1) Mouse Monoclonal Primary Antibody
VarMap™ Pan-Cancer NGS Panel
Vartrace® BRAF Panel
iPLEX® HS Lung Panel
oncoReveal™ Core LBx
oncoReveal™ Essential LBx
oncoReveal™ Fusion LBx Panel
oncoReveal™ Multi-Cancer with CNV & RNA Fusion Panel
oncoReveal™ Solid Tumor v2 Panel
›
Associations
(849)
News
Trials
VERI cancer hierarchy
Reset Filters
BRAF V600
Melanoma
BRAF V600
Melanoma
atezolizumab + vemurafenib + cobimetinib
Sensitive: A1 - Approval
atezolizumab + vemurafenib + cobimetinib
Sensitive
:
A1
atezolizumab + vemurafenib + cobimetinib
Sensitive: A1 - Approval
atezolizumab + vemurafenib + cobimetinib
Sensitive
:
A1
BRAF V600E
Colorectal Cancer
BRAF V600E
Colorectal Cancer
cetuximab + binimetinib + encorafenib
Sensitive: A1 - Approval
cetuximab + binimetinib + encorafenib
Sensitive
:
A1
cetuximab + binimetinib + encorafenib
Sensitive: A1 - Approval
cetuximab + binimetinib + encorafenib
Sensitive
:
A1
BRAF V600E
Colorectal Cancer
BRAF V600E
Colorectal Cancer
cetuximab + encorafenib
Sensitive: A1 - Approval
cetuximab + encorafenib
Sensitive
:
A1
cetuximab + encorafenib
Sensitive: A1 - Approval
cetuximab + encorafenib
Sensitive
:
A1
BRAF V600E
Melanoma
BRAF V600E
Melanoma
dabrafenib
Sensitive: A1 - Approval
dabrafenib
Sensitive
:
A1
dabrafenib
Sensitive: A1 - Approval
dabrafenib
Sensitive
:
A1
BRAF V600E
Non Small Cell Lung Cancer
BRAF V600E
Non Small Cell Lung Cancer
trametinib + dabrafenib
Sensitive: A1 - Approval
trametinib + dabrafenib
Sensitive
:
A1
trametinib + dabrafenib
Sensitive: A1 - Approval
trametinib + dabrafenib
Sensitive
:
A1
BRAF V600E
Thyroid Gland Anaplastic Carcinoma
BRAF V600E
Thyroid Gland Anaplastic Carcinoma
trametinib + dabrafenib
Sensitive: A1 - Approval
trametinib + dabrafenib
Sensitive
:
A1
trametinib + dabrafenib
Sensitive: A1 - Approval
trametinib + dabrafenib
Sensitive
:
A1
BRAF V600E
Thyroid Gland Anaplastic Carcinoma
BRAF V600E
Thyroid Gland Anaplastic Carcinoma
dabrafenib
Sensitive: A1 - Approval
dabrafenib
Sensitive
:
A1
dabrafenib
Sensitive: A1 - Approval
dabrafenib
Sensitive
:
A1
BRAF V600E
Melanoma
BRAF V600E
Melanoma
trametinib + dabrafenib
Sensitive: A1 - Approval
trametinib + dabrafenib
Sensitive
:
A1
trametinib + dabrafenib
Sensitive: A1 - Approval
trametinib + dabrafenib
Sensitive
:
A1
BRAF V600
Melanoma
BRAF V600
Melanoma
binimetinib + encorafenib
Sensitive: A1 - Approval
binimetinib + encorafenib
Sensitive
:
A1
binimetinib + encorafenib
Sensitive: A1 - Approval
binimetinib + encorafenib
Sensitive
:
A1
BRAF V600K
Melanoma
BRAF V600K
Melanoma
trametinib + dabrafenib
Sensitive: A1 - Approval
trametinib + dabrafenib
Sensitive
:
A1
trametinib + dabrafenib
Sensitive: A1 - Approval
trametinib + dabrafenib
Sensitive
:
A1
BRAF V600E
Melanoma
BRAF V600E
Melanoma
vemurafenib + cobimetinib
Sensitive: A1 - Approval
vemurafenib + cobimetinib
Sensitive
:
A1
vemurafenib + cobimetinib
Sensitive: A1 - Approval
vemurafenib + cobimetinib
Sensitive
:
A1
BRAF V600
Melanoma
BRAF V600
Melanoma
vemurafenib + cobimetinib
Sensitive: A1 - Approval
vemurafenib + cobimetinib
Sensitive
:
A1
vemurafenib + cobimetinib
Sensitive: A1 - Approval
vemurafenib + cobimetinib
Sensitive
:
A1
BRAF V600E
Melanoma
BRAF V600E
Melanoma
vemurafenib
Sensitive: A1 - Approval
vemurafenib
Sensitive
:
A1
vemurafenib
Sensitive: A1 - Approval
vemurafenib
Sensitive
:
A1
BRAF V600E
Melanoma
BRAF V600E
Melanoma
trametinib
Sensitive: A1 - Approval
trametinib
Sensitive
:
A1
trametinib
Sensitive: A1 - Approval
trametinib
Sensitive
:
A1
BRAF V600
Melanoma
BRAF V600
Melanoma
dabrafenib
Sensitive: A1 - Approval
dabrafenib
Sensitive
:
A1
dabrafenib
Sensitive: A1 - Approval
dabrafenib
Sensitive
:
A1
BRAF V600
Melanoma
BRAF V600
Melanoma
trametinib + dabrafenib
Sensitive: A1 - Approval
trametinib + dabrafenib
Sensitive
:
A1
trametinib + dabrafenib
Sensitive: A1 - Approval
trametinib + dabrafenib
Sensitive
:
A1
BRAF V600
Melanoma
BRAF V600
Melanoma
trametinib
Sensitive: A1 - Approval
trametinib
Sensitive
:
A1
trametinib
Sensitive: A1 - Approval
trametinib
Sensitive
:
A1
BRAF V600K
Melanoma
BRAF V600K
Melanoma
trametinib
Sensitive: A1 - Approval
trametinib
Sensitive
:
A1
trametinib
Sensitive: A1 - Approval
trametinib
Sensitive
:
A1
BRAF V600E
Solid Tumor
BRAF V600E
Solid Tumor
trametinib + dabrafenib
Sensitive: A1 - Approval
trametinib + dabrafenib
Sensitive
:
A1
trametinib + dabrafenib
Sensitive: A1 - Approval
trametinib + dabrafenib
Sensitive
:
A1
BRAF V600
Melanoma
BRAF V600
Melanoma
vemurafenib
Sensitive: A1 - Approval
vemurafenib
Sensitive
:
A1
vemurafenib
Sensitive: A1 - Approval
vemurafenib
Sensitive
:
A1
BRAF V600
Non Small Cell Lung Cancer
BRAF V600
Non Small Cell Lung Cancer
trametinib + dabrafenib
Sensitive: A1 - Approval
trametinib + dabrafenib
Sensitive
:
A1
trametinib + dabrafenib
Sensitive: A1 - Approval
trametinib + dabrafenib
Sensitive
:
A1
BRAF V600K
Melanoma
BRAF V600K
Melanoma
binimetinib + encorafenib
Sensitive: A1 - Approval
binimetinib + encorafenib
Sensitive
:
A1
binimetinib + encorafenib
Sensitive: A1 - Approval
binimetinib + encorafenib
Sensitive
:
A1
BRAF V600E
Melanoma
BRAF V600E
Melanoma
binimetinib + encorafenib
Sensitive: A1 - Approval
binimetinib + encorafenib
Sensitive
:
A1
binimetinib + encorafenib
Sensitive: A1 - Approval
binimetinib + encorafenib
Sensitive
:
A1
BRAF V600K
Melanoma
BRAF V600K
Melanoma
vemurafenib + cobimetinib
Sensitive: A1 - Approval
vemurafenib + cobimetinib
Sensitive
:
A1
vemurafenib + cobimetinib
Sensitive: A1 - Approval
vemurafenib + cobimetinib
Sensitive
:
A1
BRAF V600
Melanoma
BRAF V600
Melanoma
nivolumab
Sensitive: A1 - Approval
nivolumab
Sensitive
:
A1
nivolumab
Sensitive: A1 - Approval
nivolumab
Sensitive
:
A1
BRAF V600E
Glioma
BRAF V600E
Glioma
trametinib + dabrafenib
Sensitive: A1 - Approval
trametinib + dabrafenib
Sensitive
:
A1
trametinib + dabrafenib
Sensitive: A1 - Approval
trametinib + dabrafenib
Sensitive
:
A1
BRAF V600 wild-type
Melanoma
BRAF V600 wild-type
Melanoma
nivolumab + ipilimumab
Sensitive: A1 - Approval
nivolumab + ipilimumab
Sensitive
:
A1
nivolumab + ipilimumab
Sensitive: A1 - Approval
nivolumab + ipilimumab
Sensitive
:
A1
BRAF V600
Melanoma
BRAF V600
Melanoma
pembrolizumab
Sensitive: A1 - Approval
pembrolizumab
Sensitive
:
A1
pembrolizumab
Sensitive: A1 - Approval
pembrolizumab
Sensitive
:
A1
BRAF fusion
Glioma
BRAF fusion
Glioma
tovorafenib
Sensitive: A1 - Approval
tovorafenib
Sensitive
:
A1
tovorafenib
Sensitive: A1 - Approval
tovorafenib
Sensitive
:
A1
BRAF V600E
Non Small Cell Lung Cancer
BRAF V600E
Non Small Cell Lung Cancer
binimetinib + encorafenib
Sensitive: A1 - Approval
binimetinib + encorafenib
Sensitive
:
A1
binimetinib + encorafenib
Sensitive: A1 - Approval
binimetinib + encorafenib
Sensitive
:
A1
BRAF V600
Glioma
BRAF V600
Glioma
tovorafenib
Sensitive: A1 - Approval
tovorafenib
Sensitive
:
A1
tovorafenib
Sensitive: A1 - Approval
tovorafenib
Sensitive
:
A1
BRAF rearrangement
Glioma
BRAF rearrangement
Glioma
tovorafenib
Sensitive: A1 - Approval
tovorafenib
Sensitive
:
A1
tovorafenib
Sensitive: A1 - Approval
tovorafenib
Sensitive
:
A1
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login